EP4103147A4 - Composition destinée à protéger la peau contre une substance, une lumière et un stress nocifs - Google Patents

Composition destinée à protéger la peau contre une substance, une lumière et un stress nocifs Download PDF

Info

Publication number
EP4103147A4
EP4103147A4 EP21911623.3A EP21911623A EP4103147A4 EP 4103147 A4 EP4103147 A4 EP 4103147A4 EP 21911623 A EP21911623 A EP 21911623A EP 4103147 A4 EP4103147 A4 EP 4103147A4
Authority
EP
European Patent Office
Prior art keywords
protecting
stress
composition
light
harmful substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP21911623.3A
Other languages
German (de)
English (en)
Other versions
EP4103147A1 (fr
Inventor
Kwang Nyeon Kim
Yulia MIROMOVA
Aleksei PROKOPOV
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
INCOSPHARM CORP
Zoe Bio Inc
Medical Bioengineering Systems Ltd
Original Assignee
INCOSPHARM CORP
Zoe Bio Inc
Medical Bioengineering Systems Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by INCOSPHARM CORP, Zoe Bio Inc, Medical Bioengineering Systems Ltd filed Critical INCOSPHARM CORP
Publication of EP4103147A1 publication Critical patent/EP4103147A1/fr
Publication of EP4103147A4 publication Critical patent/EP4103147A4/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/442—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/447—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP21911623.3A 2020-12-24 2021-12-24 Composition destinée à protéger la peau contre une substance, une lumière et un stress nocifs Pending EP4103147A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020200183691A KR102378053B1 (ko) 2020-12-24 2020-12-24 유해물질 및 광에 대한 피부보호용 조성물
PCT/KR2021/019872 WO2022139558A1 (fr) 2020-12-24 2021-12-24 Composition destinée à protéger la peau contre une substance, une lumière et un stress nocifs

Publications (2)

Publication Number Publication Date
EP4103147A1 EP4103147A1 (fr) 2022-12-21
EP4103147A4 true EP4103147A4 (fr) 2023-08-09

Family

ID=80935587

Family Applications (1)

Application Number Title Priority Date Filing Date
EP21911623.3A Pending EP4103147A4 (fr) 2020-12-24 2021-12-24 Composition destinée à protéger la peau contre une substance, une lumière et un stress nocifs

Country Status (3)

Country Link
EP (1) EP4103147A4 (fr)
KR (1) KR102378053B1 (fr)
WO (1) WO2022139558A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023200874A1 (fr) * 2022-04-13 2023-10-19 ALASTIN Skincare, Inc. Combinaison d'octapeptide et d'acide hyaluronique de masse moléculaire élevée pour application topique

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111432778A (zh) * 2017-11-30 2020-07-17 H&A帕玛科株式会社 利用磷脂酰丝氨酸/阴离子表面活性剂/氯化钙的脂质卷

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2783169B1 (fr) * 1998-09-15 2001-11-02 Sederma Sa Utilisation cosmetique ou dermopharmaceutique de peptides pour la cicatrisation et pour l'amelioration de l'aspect cutane lors du vieillissement naturel ou accelere (heliodermie, pollution)
WO2015113307A1 (fr) * 2014-01-30 2015-08-06 Dow Corning Corporation Compositions pour application sur la peau pour réduire l'adhésion de particules de pollution sur la peau et leurs procédés de préparation
KR20160128889A (ko) * 2015-04-29 2016-11-08 주식회사 엘지생활건강 비타민 또는 이의 유도체를 함유한 용해성 마이크로니들
KR101684415B1 (ko) * 2016-06-30 2016-12-07 주식회사 뉴앤뉴 리포좀화된 헥사카복시메틸 다이펩타이드-12를 유효성분으로 함유하는 유중수형 메이크업 화장료 조성물 및 이의 제조방법
KR101836781B1 (ko) * 2017-10-20 2018-04-19 한승우 동력전달 장치, 이를 포함하는 차량 및 그 작동 제어 방법
CN116870157A (zh) * 2017-10-20 2023-10-13 日本乐敦制药株式会社 皮肤障碍改善用组合物
CN112367968B (zh) * 2018-07-06 2023-06-16 安医健有限公司 包含肽复合物作为有效成分的用于去除或吸附微尘的化妆品组合物
KR102099269B1 (ko) * 2020-01-22 2020-04-10 신승연 2-파트 스킨 케어 제제
KR20200078433A (ko) * 2020-06-11 2020-07-01 주식회사 리턴바이오 다양한 성장인자와 펩타이드를 함유하는 주름개선 및 미백용 화장료 조성물

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111432778A (zh) * 2017-11-30 2020-07-17 H&A帕玛科株式会社 利用磷脂酰丝氨酸/阴离子表面活性剂/氯化钙的脂质卷

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE GNPD [online] MINTEL; 28 August 2020 (2020-08-28), ANONYMOUS: "French Spa Green Mud Cleanser", XP055939911, retrieved from https://www.gnpd.com/sinatra/recordpage/8062851/ Database accession no. 8062851 *
See also references of WO2022139558A1 *

Also Published As

Publication number Publication date
WO2022139558A1 (fr) 2022-06-30
KR102378053B1 (ko) 2022-03-25
EP4103147A1 (fr) 2022-12-21

Similar Documents

Publication Publication Date Title
EP3846610A4 (fr) Composés et formulations de revêtements protecteurs
EP3770213A4 (fr) Composition pour pelliplacage, agent d'étanchéité pour pelliplace et corps d'emballage pour pelliplage
EP3782998A4 (fr) Composé de pyrrolotriazine substitué, composition pharmaceutique et utilisation associées
EP3948991A4 (fr) Composition pour anode, et film protecteur, anode et dispositif la comprenant
EP4081308A4 (fr) Agents de dégradation de smarca et leurs utilisations
EP3928607A4 (fr) Composé hétérocyclique et composition de lutte contre les arthropodes nuisibles le contenant
EP3989925A4 (fr) Composition pour teindre les fibres de kératine et utilisation associée
EP3773424A4 (fr) Compositions de coiffure comprenant des polygalactomannanes, et leur méthode d'utilisation
EP3991716A4 (fr) Composition de protection de la peau à base d'acide hyaluronique, son procédé de préparation et son application
EP4063489A4 (fr) Composition et utilisation correspondante
EP4103147A4 (fr) Composition destinée à protéger la peau contre une substance, une lumière et un stress nocifs
EP4223759A4 (fr) Composé pyrazolopyridazinone, composition pharmaceutique le contenant et son utilisation
EP3750968A4 (fr) Photosensibilisateur et composition durcissable par rayonnement d'énergie active
EP4119146A4 (fr) Phillyrine ciblant la 3 clpro, son dérivé et son utilisation contre le nouveau coronavirus
EP4056683A4 (fr) Organoïde cérébral et utilisation correspondante
EP3636266A4 (fr) Inhibiteur de maladies de la peau, et composition pour l'inhibition de maladies de la peau
EP3826658A4 (fr) Compositions de lycopène et procédés de protection de la peau contre le rayonnement ultraviolet
EP3995122A4 (fr) Composition pour couvercle de protection et capuchon
EP4114362A4 (fr) Formulations nanomédicamenteuses de cannabidiol et leurs méthodes d'utilisation
EP3908583A4 (fr) Agents de dégradation de dot1l et utilisations associées
EP3816229A4 (fr) Composition de silicone et agent de traitement de fibre utilisant celle-ci
EP4001262A4 (fr) Composé contenant du phényle, intermédiaire correspondant, procédé de préparation correspondant, et application correspondante
EP3955913A4 (fr) Compositions et procédés destinés au traitement du diabète
EP3816162A4 (fr) Composé diarylpyrazole, composition le comprenant et utilisation associée
EP3970800A4 (fr) Agent de protection contre les polluants atmospheriques ainsi que composition pour la protection contre les polluants atmospheriques

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20220914

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

A4 Supplementary search report drawn up and despatched

Effective date: 20230712

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 38/05 20060101ALI20230706BHEP

Ipc: A61K 38/08 20190101ALI20230706BHEP

Ipc: A61K 38/06 20060101ALI20230706BHEP

Ipc: A61Q 19/08 20060101ALI20230706BHEP

Ipc: A61Q 17/04 20060101ALI20230706BHEP

Ipc: A61K 8/73 20060101ALI20230706BHEP

Ipc: A61K 8/49 20060101ALI20230706BHEP

Ipc: A61K 8/44 20060101ALI20230706BHEP

Ipc: A61K 8/64 20060101AFI20230706BHEP

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)